


Ensho Therapeutics Email Formats
Biotechnology Research • United States • 1-10 Employees
Ensho Therapeutics Email Formats
Ensho Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@enshorx.com), used 88.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@enshorx.com | 88.9% |
{first initial}{last name} | jdoe@enshorx.com | 11.1% |
Key Contacts at Ensho Therapeutics
Enoch Kariuki
Strategic Advisor To The Board Of Directors
Neena Bitritto-Garg
Founder, President & Ceo
Company overview
| Headquarters | United States |
| Phone number | +19732413669 |
| Website | |
| NAICS | 541714 |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
About Ensho Therapeutics
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The company’s initial focus is on a pipeline of oral, selective small molecule inhibitors of lymphocyte homing integrin α4β7 for IBD, a mechanism already validated by a commercially available antibody. Ensho’s assets were acquired from EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd., that is focused on gastrointestinal disease. Ensho is preparing to initiate a Phase 2 clinical program in UC with NSHO-101, the lead asset in the company’s pipeline.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Ensho Therapeutics has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Explore Ensho Therapeutics's funding history, including investment rounds, total capital raised, and key backers.
Ensho Therapeutics Tech Stack
Discover the technologies and tools that power Ensho Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Web servers
JavaScript libraries
Tag managers
Miscellaneous
Analytics
JavaScript libraries
Frequently asked questions
4.8
40,000 users



